Cargando…
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report
Patient: Male, 48-year-old Final Diagnosis: Neuroleptic malignant syndrome Symptoms: Altered mental status • fatigue • fever • generalized weakness • loss of appetite Medication: — Clinical Procedure: — Specialty: Critical Care Medicine • Endocrinology and Metabolic • Neurology OBJECTIVE: Unusual cl...
Autores principales: | Mizuno, Tomohito, Takahashi, Riku, Kamiyama, Takahiro, Suzuki, Atsushi, Suzuki, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087139/ https://www.ncbi.nlm.nih.gov/pubmed/35514081 http://dx.doi.org/10.12659/AJCR.936217 |
Ejemplares similares
-
Tozinameran/valproate: Neuroleptic malignant syndrome and adrenal insufficiency: case report
Publicado: (2022) -
Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent
por: Yıldırım, Veli, et al.
Publicado: (2017) -
Acute adrenal insufficiency in a patient with panhypopituitarism after vaccination against COVID-19 (BNT162b2 Pfizer-BioNTech)
por: González López, Javier, et al.
Publicado: (2022) -
Adrenal insufficiency in a haemodialysis patient
por: Suzuki, Ryuji, et al.
Publicado: (2010) -
PSAT034 A Case of Adrenal Crisis in Association With a Febrile Response to the bnt162b2 mRNA COVID-19 (Pfizer) Vaccine Heralding a Diagnosis of Primary Adrenal Insufficiency.
por: Kamimoto, Jorge J, et al.
Publicado: (2022)